Instil Bio (TIL) Income towards Parent Company (2020 - 2026)

Instil Bio's Income towards Parent Company history runs 7 years deep, the most recent figure standing at -$7.9 million for Q1 2026.

• In Q1 2026, Income towards Parent Company rose 74.14% year-over-year to -$7.9 million; the TTM figure through Mar 2026 stood at -$58.0 million (up 29.46% YoY), while the FY2025 annual figure was -$80.6 million, up 61.26% from the prior year.
• Income towards Parent Company for Q1 2026 stood at -$7.9 million, up from -$10.4 million in the prior quarter.
• The five-year high for Income towards Parent Company was -$7.9 million in Q1 2026, with the low at -$67.4 million in Q3 2023.
• The 5-year median for Income towards Parent Company is -$24.0 million (2025), against an average of -$32.0 million.
• The sharpest annual moves came in 2022 and 2023: Income towards Parent Company tumbled 133.99% in 2022, then jumped 76.0% in 2023.
• Instil Bio's Income towards Parent Company stood at -$53.8 million in 2022, then surged by 76.0% to -$12.9 million in 2023, then dropped by 4.22% to -$13.5 million in 2024, then increased by 22.96% to -$10.4 million in 2025, then gained by 24.03% to -$7.9 million in 2026.
• Business Quant data shows TIL's Income towards Parent Company at -$7.9 million in Q1 2026, -$10.4 million in Q4 2025, and -$15.7 million in Q3 2025.